-
Company Insights
Innovation and Patenting activity of Learning Technologies Group plc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Learning Technologies Group plc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Track & Monitor
Artificial intelligence in automotive: End-to-end learning models
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s End-to-end learning models segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Product Insights
NewLikelihood of Approval Analysis for Duchenne Muscular Dystrophy
Overview How likely is it that the drugs in Duchenne Muscular Dystrophy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Duchenne Muscular Dystrophy Overview Duchenne muscular dystrophy (DMD) is a genetic...
-
Product Insights
NewLikelihood of Approval Analysis for Developmental Disorders
Overview How likely is it that the drugs in Developmental Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Developmental Disorders Overview Developmental disorders comprise a spectrum of conditions affecting physical,...
-
Company Insights
NewMorgan Stanley – Digital Transformation Strategies
Morgan Stanley Digital Transformation Strategies Overview Morgan Stanley is utilizing AI and machine learning to improve its wealth and asset management operations and other operational processes. AI, big data, cloud, and blockchain are among the key technologies under focus for the company. The annual ICT spending of Morgan Stanley was estimated at $4.6 billion in 2023. A major share of this spending is earmarked for acquiring software, ICT services, and network and communications from vendors. Morgan Stanley is utilizing AI...
-
Track & Monitor
Artificial intelligence in technology: Deep reinforcement learning
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the technology industry’s Deep reinforcement learning segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Track & Monitor
Artificial intelligence in technology: Deep learning inference engines
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the technology industry’s Deep learning inference engines segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered...
-
Product Insights
NewLikelihood of Approval Analysis for Eosinophilia
Overview How likely is it that the drugs in Eosinophilia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Eosinophilia Overview Eosinophilia is defined as an increase of circulating eosinophils. The count...
-
Product Insights
NewLikelihood of Approval Analysis for Diabetic Nephropathy
Overview How likely is it that the drugs in Diabetic Nephropathy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Diabetic Nephropathy Overview Diabetic nephropathy is damage to the kidney occurring due...
-
Product Insights
NewLikelihood of Approval Analysis for Diabetic Neuropathy
Overview How likely is it that the drugs in Diabetic Neuropathy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Diabetic Neuropathy Overview Diabetic neuropathy, a common complication of diabetes, is damage...